Re:Pair Genomics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Re:Pair Genomics General Information

Description

Developer of customized gene regulatory elements designed to speed up gene therapy research while maintaining high accuracy. The company's elements offer benefits such as generating output within minutes after screening through multiple databases, and these elements are widely used by researchers to reduce off-targeting effects that are normally present with ubiquitous promoters, enabling the medical industry to generate proper designs of gene regulatory elements for each cell type.

Contact Information

Formerly Known As
Re:Pair Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 33 National Pine Drive
  • Vaughan, Ontario L6A 3M2
  • Canada
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Corporate Office
  • 33 National Pine Drive
  • Vaughan, Ontario L6A 3M2
  • Canada

Re:Pair Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Re:Pair Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Accelerator/Incubator 29-Apr-2026 Completed Generating Revenue
13. Seed Round 06-May-2025 In Progress Generating Revenue
12. Grant 02-May-2025 Completed Generating Revenue
11. Grant 04-Apr-2025 Completed Generating Revenue
10. Accelerator/Incubator 27-Mar-2025 Completed Generating Revenue
9. Accelerator/Incubator 27-Mar-2025 Completed Generating Revenue
8. Accelerator/Incubator 14-Mar-2025 Completed Generating Revenue
7. Grant 10-Feb-2025 Completed Generating Revenue
6. Accelerator/Incubator 18-Oct-2024 $14.7K $29.3K Completed Generating Revenue
5. Accelerator/Incubator 26-Apr-2024 $7.32K $14.6K Completed Generating Revenue
To view Re:Pair Genomics’s complete valuation and funding history, request access »

Re:Pair Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Re:Pair Genomics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
YSpace (Toronto) Accelerator/Incubator
BioHubNet Corporation Minority
Desjardins Capital PE/Buyout Minority
Innovation Factory (Hamilton) Accelerator/Incubator Minority
CABHI Corporate Venture Capital
You’re viewing 5 of 11 investors. Get the full list »

Re:Pair Genomics FAQs

  • When was Re:Pair Genomics founded?

    Re:Pair Genomics was founded in 2019.

  • Where is Re:Pair Genomics headquartered?

    Re:Pair Genomics is headquartered in Vaughan, Canada.

  • What is the size of Re:Pair Genomics?

    Re:Pair Genomics has 12 total employees.

  • What industry is Re:Pair Genomics in?

    Re:Pair Genomics’s primary industry is Other Healthcare Technology Systems.

  • Is Re:Pair Genomics a private or public company?

    Re:Pair Genomics is a Private company.

  • What is Re:Pair Genomics’s current revenue?

    The current revenue for Re:Pair Genomics is .

  • How much funding has Re:Pair Genomics raised over time?

    Re:Pair Genomics has raised $58.6K.

  • Who are Re:Pair Genomics’s investors?

    YSpace (Toronto), BioHubNet, Desjardins Capital, Innovation Factory (Hamilton), and CABHI are 5 of 11 investors who have invested in Re:Pair Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process